When children in Africa with sickle cell anemia receive hydroxyurea, evidence points to reductions in both complications of sickle cell anemia and risk of infections.

When children in Africa with sickle cell anemia receive hydroxyurea, evidence points to reductions in both complications of sickle cell anemia and risk of infections.

This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal